论文部分内容阅读
分子靶向治疗是一种新的肿瘤治疗手段,它能够特异性地作用于肿瘤发生发展中起关键作用的靶分子及其调控的信号传导通路,从而达到治疗肿瘤的目的。在头颈肿瘤分子靶向治疗的临床实验中,靶向表皮生长因子受体(EGFR)、血管内皮细胞生长因子(VEGF)和靶向环氧化酶-2(COX-2)的药物治
Molecular targeted therapy is a new method of oncology treatment, which can specifically target the target molecules that play a key role in the development of tumors and their regulatory signal transduction pathways, so as to achieve the purpose of treating tumors. In clinical trials of molecular targeted therapies for head and neck cancer, drugs that target epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and cyclooxygenase-2 (COX-2)